Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in South Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Carolina
| Provider | Medicare | Services |
|---|---|---|
| Assure Laboratory Inc | $50.24 | 1.5K |
| Vikor Scientific, Llc | $50.28 | 805 |
South Carolina Pricing in Context
In South Carolina, CPT code 87635 (Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen) carries an average Medicare payment of $49.66 — 1% below the national benchmark of $50.08. 859 providers across the state submitted claims for this procedure in 2023, performing 22.4K total services. Individual payments in SC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Carolina is $115.64, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in South Carolina lands near $116.71, with self-pay cash prices typically around $69.05. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cost in South Carolina?
The average Medicare payment for Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in South Carolina is $49.66, which is 1% below the national average of $50.08. Providers in SC typically bill $115.64 for this procedure.
What does Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cost with insurance in South Carolina?
With commercial insurance in South Carolina, Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen costs an estimated $116.71. Without insurance, the estimated cash price is $69.05. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in South Carolina?
859 providers in South Carolina billed Medicare for Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in 2023, performing 22.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cheaper in South Carolina than the national average?
Yes — Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen costs 1% below the national average in South Carolina. The state average Medicare payment is $49.66 compared to $50.08 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.